EMA Authorised: Brukinsa (zanubrutinib) — BeOne Medicines Ireland Limited

View source ↗

Summary

The European Medicines Agency authorised Brukinsa (zanubrutinib) for Waldenström macroglobulinemia, with BeOne Medicines Ireland Limited as the marketing author…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)

Snippet

Status: Authorised. Therapeutic area: Waldenstrom Macroglobulinemia. MAH: BeOne Medicines Ireland Limited. Decision date: 24/10/2025